Revvity, Inc. (RVTY) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Revvity, Inc. (RVTY) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

RVTY

Market Closed

Revvity, Inc.

NYSEHealthcare Medical - Diagnostics & Research

11.00K employees

CEO: Prahlad R. Singh

Founded: 1965

$100.00

+$0.00(+NaN%)

Market Cap

11.16B

Beta

1.11

52W Range

N/A

Dividend Yield

0.28%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

53.1%

14.6%

CAGR: -9.7%

Profit after direct costs

Operating Margin

12.5%

-13.1%

CAGR: -28.2%

Core business profitability

Net Margin

8.5%

-18.3%

CAGR: -28.9%

Bottom line profitability

Revenue Growth

3.7%

YoY

CAGR: -7.1%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how RVTY allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

53.1%

$1.52B

Operating Margin

12.5%

$356.63M

Net Margin

8.5%

$241.68M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	3.83B	3.31B	2.75B	2.76B	2.86B	3.7%
Cost of Revenue	(1.55B)	(1.55B)	(1.43B)	(1.43B)	(1.34B)	-6.4%
Gross Profit	2.28B	1.76B	1.32B	1.32B	1.52B	14.6%
Operating Expenses
Research & Development	(200.34M)	(221.62M)	(216.58M)	(196.84M)	(215.84M)	9.7%
Selling, General & Administrative	(741.61M)	(757.99M)	(706.12M)	(715.30M)	(945.28M)	32.2%
Depreciation & Amortization	(311.44M)	(427.00M)	(431.77M)	(427.85M)	(302.26M)	-29.4%
Operating Income (EBIT)	1.34B	781.12M	399.49M	410.52M	356.63M	-13.1%
Non-Operating Items
Interest Income	2.24M	3.59M	72.13M	73.19M	31.10M	-57.5%
Interest Expense	(102.13M)	(103.95M)	(98.81M)	(96.28M)	(92.19M)	-4.3%
Other Income/Expenses (Net)	-136.42M	-129.28M	-216.51M	-94.39M	-88.36M	-6.4%
Income Before Tax	1.20B	651.84M	182.98M	316.13M	268.28M	-15.1%
Income Tax Expense	(314.15M)	(139.16M)	(3.47M)	(33.05M)	(25.80M)	-21.9%
Net Income	943.16M	569.18M	-118.38M	295.83M	241.68M	-18.3%
Per Share Metrics
Earnings Per Share (Basic)	$8	$5	$-1	$2	$2	-13.7%
Weighted Avg Shares Outstanding	116.17M	126.16M	124.70M	122.76M	113.21M	-7.8%
Weighted Avg Shares Outstanding (Diluted)	116.67M	126.43M	124.81M	122.82M	113.21M	-7.8%
EBITDA	1.62B	1.18B	713.56M	840.25M	662.72M	-21.1%

Explore RVTY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

RVTY in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Medical - Diagnostics & Research

Browse industry stocks →